Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China

NCT06655090 · clinicaltrials.gov ↗

RECRUITING

Status

10000

Enrollment

OTHER

Sponsor class

Conditions

Interstitial Lung Disease (ILD)

Sponsor

Dai Huaping

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]